台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP027: Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy- naïve patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): Taiwan subgroup analysis of an Asian multiregional study

2017-06-01 • 觀看: 3242 • 回應: 0 • doc
MP026: The impact of different treatment modality in global quality of life among patients of prostate cancer

2017-06-01 • 觀看: 1801 • 回應: 0 • doc
MP025: Urodynamic changes in patients with prostate cancer who have undergone robotic-assisted radical prostatectomy: a comparison with laparoscopic radical prostatectomy

2017-06-01 • 觀看: 1833 • 回應: 0 • doc
MP024: Prognosis of prostate cancer with initial PSA at diagnosis beyond 1000 ng/ml

2017-06-01 • 觀看: 1682 • 回應: 0 • doc
MP023: Outcome of patients with metastatic castration-resistant prostate cancer after progressive disease of abiraterone acetate

2017-06-01 • 觀看: 1892 • 回應: 0 • doc
MP022: The value of prostate health index to predict magnetic resonance imaging lesions during active surveillance: A prospective cohort in Taiwan

2017-06-01 • 觀看: 1964 • 回應: 0 • doc
MP021: Prostate health index (PHI) improve prostate cancer detection at initial biopsy in Taiwanese men with PSA 4-10ng/ml

2017-06-01 • 觀看: 1977 • 回應: 0 • doc
2017TUA 形象影片0505

2017-06-01 • 觀看: 1 • 回應: 0 • 影片
用user2測試小檔上傳

2017-06-01 • 觀看: 1 • 回應: 0 • 影片
MP020: Dynamic changes of quality of life in bladder cancer survivors with and without radical cystectomy

2017-06-01 • 觀看: 1885 • 回應: 0 • doc
MP019: Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells

2017-06-01 • 觀看: 1956 • 回應: 0 • doc
MP015: Comparison of the efficacy of adjuvant MEC (methotrexate, epirubicin and cisplatin) and GC (gemcitabine and cisplatin) in advanced upper tract urothelial carcinoma

2017-06-01 • 觀看: 2122 • 回應: 0 • doc